Convalescent Plasma Trial in COVID -19 Patients

Clinical Trial ID NCT04356534

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04356534

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Covariate imbalance and random allocation in clinical trials. Stat Med 1989 5.41
2 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020 4.49
3 Testing for baseline balance in clinical trials. Stat Med 1994 3.01
4 Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 2011 1.68
5 Internal pilot studies for estimating sample size. Stat Med 1995 1.21
6 Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect 2004 0.93
7 P-values in baseline tables of randomised controlled trials are inappropriate but still common in high impact journals. Eur J Prev Cardiol 2012 0.92
8 Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone. J Infect 2016 0.76
Next 100